| 1 |
Kharel S, Bist A, Mishra SK. Ventilator-associated pneumonia among ICU patients in WHO Southeast Asian region: A systematic review[J]. PLoS One, 2021, 16(3): e0247832.
|
| 2 |
张 鹏，周 健，王耀丽，等. 外周血Th17细胞对呼吸机相关性肺炎的早期诊断价值[J/CD]. 中华肺部疾病杂志(电子版), 2016, 9(2): 150-153.
|
| 3 |
邹燕子，陈茂刚，朱明训，等. 呼吸机相关肺炎患者病原菌分布、炎症指标及耐药性分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(4): 492-495.
|
| 4 |
谢柏梅，敬 梅，路晓艳，等. CPIS评分及血清PCT在慢性阻塞性肺疾病呼吸机相关性肺炎诊断和预后判断中的应用价值[J]. 临床和实验医学杂志，2018, 17(15): 1617-1620.
|
| 5 |
Cisneros JM, Rosso-Fernández CM, Roca-Oporto C, et al. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial[J]. Crit Care, 2019, 23(1): 383.
|
| 6 |
Z Mazlan M, A H Ismail M, Ali S, et al. Efficacy and safety of the point-of-care procalcitonin test for determining the antibiotic treatment duration in patients with ventilator-associated pneumonia in the intensive care unit: a randomised controlled trial[J]. Anaesthesiol Intensive Ther, 2021, 53(3): 207-214.
|
| 7 |
Millot G, Voisin B, Loiez C, et al. The next generation of rapid point-of-care testing identification tools for ventilator-associated pneumonia[J]. Ann Transl Med, 2017, 5(22): 451.
|
| 8 |
Abo-Hagar HH, Abo-Elezz AAE, Mehrez M, et al. Diagnostic efficacy of serum amyloid A protein and soluble intercellular adhesion molecule 1 in pediatric ventilator-associated pneumonia[J]. J Intensive Care Med, 2019, 34(6): 503-510.
|
| 9 |
郎耀雄，杨 芸，王 鑫. APACHEⅡ评分对机械通气患者相关指标及预后的评估分析[J]. 中华医院感染学杂志，2019, 29(9): 1315-1318.
|
| 10 |
中华医学会重症医学分会. 呼吸机相关性肺炎诊断、预防和治疗指南(2013)[J]. 中华内科杂志，2013, 52(6): 524-543.
|
| 11 |
Liu D, Su LX, Guan W, et al. Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis[J]. Respirology, 2016, 21(2): 280-288.
|
| 12 |
Principi N, Esposito S. Biomarkers in pediatric community-acquired pneumonia[J]. Int J Mol Sci, 2017, 18(2): 447.
|
| 13 |
Prendki V, Malézieux-Picard A, Azurmendi L, et al. Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study[J]. PLoS One, 2020, 15(9): e0239606.
|
| 14 |
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection[J]. Front Immunol, 2018, 9: 754.
|
| 15 |
于长锁，张金伟. 胸部CT联合血清中PCT、SAA水平检测对社区获得性肺炎病情的评价价值[J]. 中国数字医学，2020, 15(3): 126-128.
|
| 16 |
Zinellu A, Paliogiannis P, Carru C, et al. Serum amyloid A concentrations，COVID-19 severity and mortality: An updated systematic review and meta-analysis[J]. Int J Infect Dis, 2021, 105: 668-674.
|
| 17 |
何炳灵，郭述良. 降钙素原与临床肺部感染评分对老年呼吸机相关性肺炎患者病情严重程度及预后的评估价值[J]. 医学研究杂志，2016, 45(4): 49-52, 56.
|
| 18 |
谢小兵，高 云，刘 凯，等. 中性粒细胞/淋巴细胞比值对呼吸机相关性肺炎病情严重程度及预后的评估价值[J]. 河北医学，2020, 26(1): 8-13.
|
| 19 |
郑娜敏，顾 乐，吕建农. PSI评分对呼吸机相关性肺炎患者预后价值的评估[J]. 中国急救复苏与灾害医学杂志，2019, 14(4): 323-327.
|
| 20 |
Larsson J, Itenov TS, Bestle MH. Risk prediction models for mortality in patients with ventilator-associated pneumonia: A systematic review and meta-analysis[J]. J Crit Care, 2017, 37: 112-118.
|
| 21 |
Prazak J, Irincheeva I, Llewelyn MJ, et al. Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis[J]. Crit Care, 2021 25(1): 182.
|
| 22 |
卢惠伦，何海春，游世伦. 血清淀粉样蛋白A在VAP患者中的临床价值[J]. 中国热带医学，2013, 13(9): 1146-1148.
|
| 23 |
Cheng Z, Yang YJ, Jing XG, et al. Diagnostic value of HBP, PCT combined with APACHE Ⅱ score respectively in ventilator-associated pneumonia[J]. Zhonghua Yi Xue Za Zhi, 2019, 99(22): 1698-1702.
|
| 24 |
熊 英，马 芹. CRP、PTX-3联合CPIS在呼吸机相关性肺炎中的研究[J]. 国际检验医学杂志，2019, 40(13): 1630-1633.
|
| 25 |
Li J, Zhu J, Liu Q, et al. Application value of lung ultrasound in the diagnosis and severity assessment of ventilator-associated pneumonia[J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2021, 33(6): 702-707.
|
| 26 |
蔡 茜，陈思睿，朱应群. PCT与CRP水平对危重症患者呼吸机相关性肺炎预后评估的临床意义[J]. 中国医学工程，2020, 28(8): 82-84.
|
| 27 |
程路明，屈 丹，梁进娟. 降钙素原对呼吸机相关性肺炎老年重症患者预后评估价值[J]. 中国现代医药杂志，2018, 20(8): 1-5.
|
| 28 |
蔡 茜，陈思睿，朱应群. PCT与CRP水平对危重症患者呼吸机相关性肺炎预后评估的临床意义[J]. 中国医学工程，2020, 28(8): 82-84.
|
| 29 |
陈少霖，张卫星，张 声，等. 可溶性髓样细胞触发受体-1在呼吸机相关性肺炎的早期诊断及预后评估中的临床应用[J]. 中华医院感染学杂志，2017, 27(13): 2968-2971.
|
| 30 |
Po′voa P, Martin-Loeches I, Ramirez P, et al. Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAPstudy[J]. Ann Intensive Care, 2016, 6(1): 32.
|
| 31 |
Damas P, Garweg C, Monchi M, et al. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia[ISRCTN31976779][J]. Crit Care, 2006, 10(2): R52.
|
| 32 |
郭水根，徐春燕，朱先极，等. 成人社区获得性肺炎患者血清颗粒蛋白前体和淀粉样蛋白A检测的临床意义[J]. 中国感染与化疗杂志，2020, 20(3): 306-311.
|